Anti-Tumor Necrosis Factor Therapy Is Associated with Attenuated Humoral Response to Sars-Cov-2 Vaccines in Patients with Inflammatory Bowel Disease
AuthID
P-00Y-EJ3
P-00Y-EJ3
© 2024 CRACS & Inesc TEC - All Rights Reserved Política de Privacidade | Terms of Service